SCHEMBL2816181

SCHEMBL2816181

O=C(N[C@@H]1CCCc2ccc(C(=O)N3CC4(CCN(c5ccncc5)CC4)C3)cc21)c1ccccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
TAS1R3 Q7RTX0 4/20 0.45
TAS1R1 Q7RTX1 4/20 0.45
TAS1R2 Q8TE23 4/20 0.45
CTSS P25774 1/20 0.44
CYP3A4 P08684 9/20 0.43
USP2 O75604 2/20 0.43
TSHR P16473 4/20 0.43
CYP2C19 P33261 6/20 0.43
BDKRB1 P46663 1/20 0.42
CYP2C9 P11712 6/20 0.41
CYP2D6 P10635 3/20 0.41
HIF1A Q16665 3/20 0.41
CYP1A2 P05177 2/20 0.41
HSD17B10 Q99714 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2817192 0.96 ALDH1A1 (0.49) ALDH1A1TAS1R3TAS1R1TAS1R2CTSS
SCHEMBL2816543 0.96 ALDH1A1 (0.49) ALDH1A1TAS1R3TAS1R1TAS1R2CTSS
SCHEMBL2820530 0.95 ALDH1A1 (0.49) ALDH1A1TAS1R3TAS1R1TAS1R2CTSS
SCHEMBL2816144 0.95 BDKRB1 (0.43) ALDH1A1TAS1R3TAS1R1TAS1R2CYP3A4
SCHEMBL2817691 0.95 ALDH1A1 (0.51) ALDH1A1TAS1R3TAS1R1TAS1R2CTSS
SCHEMBL2820964 0.95 ALDH1A1 (0.51) ALDH1A1TAS1R3TAS1R1TAS1R2CTSS
SCHEMBL2817024 0.94 CYP3A4 (0.53) ALDH1A1CYP3A4USP2TSHRCYP2C19
SCHEMBL484272 0.94 ALDH1A1 (0.47) ALDH1A1TAS1R3TAS1R1TAS1R2CTSS
SCHEMBL2818748 0.93 ALDH1A1 (0.49) ALDH1A1TAS1R3TAS1R1TAS1R2CYP3A4
SCHEMBL2817208 0.93 CYP3A4 (0.49) ALDH1A1TAS1R3TAS1R1TAS1R2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN ALDH1A1 2086/4885TAS1R3 339/4885TAS1R1 107/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN ALDH1A1 2086/4885TAS1R3 339/4885TAS1R1 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.